Lawrence Huff, MD
Adult Reconstructive Orthopaedic Surgery · Las Vegas, NVNPI 1205034832
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,401 of the $7,109 with a category attached, or 61.9%. 16 manufacturers reported payments, led by Arthrex at 41.7% of the total. Reporting peaked in 2019 at $5,734 and has fallen 99.5% since, to $31 in 2025.
Across 51 payments — averaging $139.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Goode Surgical Inc$2K
- Stryker$721
- Smith+Nephew$293
- Shoulder Innovations, Inc.$186
- Abbott$157
- plus $478 from 10 others
What the payments were for
- Travel & lodging$1,11816%
- Food & beverage$1,59022%
- Education$4,40162%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 15 | $2,962 |
| Goode Surgical Inc | 8 | $2,313 |
| Stryker | 2 | $721 |
| Smith+Nephew | 4 | $293 |
| Shoulder Innovations, Inc. | 1 | $186 |
| Abbott | 1 | $157 |
| Pacira Therapeutics, Inc. | 1 | $138 |
| Ferring Pharmaceuticals Inc. | 4 | $65 |
| Amgen | 5 | $63 |
| Integra Lifesciences Corporation | 1 | $56 |
| Johnson & Johnson(2 entities) | 3 | $37 |
| Anika Therapeutics, Inc. | 2 | $33 |
| Orthofix Medical, Inc. | 1 | $31 |
| Acera Surgical, Inc. | 1 | $21 |
| Pfizer | 1 | $18 |
| Sanara Medtech Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AEQUALIS PERFORM$701
- InSet System$186
- Axium Sheath Braided DRG$157
- TWINFIX$149
- Zilretta$138
How this compares
Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $240 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $121 |
| Methylprednisolone | 17 | $116 |
| Meloxicam | 28 | $90 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Las Vegas
- Steven NishiyamaLas Vegas$836K
- Parminder KangLas Vegas$26K
- Justin LimtongLas Vegas$22K
- Michael WoodburyLas Vegas$11K
- Drew ImanLas Vegas$4K
- Michael RiesReno$7.7M
- Chad WattsReno$78K
- Jackson JonesReno$37K
- Shay WarrenReno$23K
- Kingsley OladejiReno$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.